A. Ecart-type, Vx = volume recevant au moins xGy BIBLIOGRAPHIE 1. Cancer CG on HF in B, others. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease, The Lancet, vol.358, issue.9291, pp.1389-1399, 2001.

I. Álvarez, M. Seguí, M. Muñoz, M. Margelí, and C. Miró, Disponible sur: http://invs.santepubliquefrance.fr/content/download Current perspectives of treatment of ductal carcinoma in situ, Cancer Treat Rev. nov, vol.7015236, issue.7, pp.507-524, 2010.

D. Allred, Ductal Carcinoma In Situ: Terminology, Classification, and Natural History, JNCI Monographs, vol.87, issue.2, pp.134-142, 2010.
DOI : 10.1016/j.suc.2007.01.006

URL : https://academic.oup.com/jncimono/article-pdf/2010/41/134/2647794/lgq035.pdf

C. Dunne, J. Burke, M. Morrow, and M. Kell, Effect of Margin Status on Local Recurrence After Breast Conservation and Radiation Therapy for Ductal Carcinoma In Situ, Journal of Clinical Oncology, vol.27, issue.10, pp.1615-1635, 2009.
DOI : 10.1200/JCO.2008.17.5182

C. Perou, T. Sorlie, and M. Eisen, Molecular portraits of human breast tumours, Nature, vol.278, issue.6797, p.747, 2000.
DOI : 10.1038/35000501

T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J. Marron et al., Repeated observation of breast tumor subtypes in independent gene expression data sets, Proceedings of the National Academy of Sciences, vol.59, issue.14, pp.8418-8423, 2003.
DOI : 10.1016/S0140-6736(02)11087-7

M. Van-de-vijver, Y. He, . Van-'t, L. Veer, H. Dai et al., A Gene-Expression Signature as a Predictor of Survival in Breast Cancer, New England Journal of Medicine, vol.347, issue.25, pp.1999-2009, 2002.
DOI : 10.1056/NEJMoa021967

T. Sørlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.179, issue.1, pp.10869-10874, 2001.
DOI : 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O

H. Chen, A. Ding, and F. Wang, Prognostic effect analysis of molecular subtype on young breast cancer patients, Chin J Cancer Res, vol.27, issue.4, p.428, 2015.

R. Dent, M. Trudeau, K. Pritchard, W. Hanna, H. Kahn et al., Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence, Clinical Cancer Research, vol.13, issue.15, pp.4429-4463, 2007.
DOI : 10.1158/1078-0432.CCR-06-3045

J. Brandt, J. Garne, I. Tengrup, and J. Manjer, Age at diagnosis in relation to survival following breast cancer: a cohort study, World Journal of Surgical Oncology, vol.13, issue.1, p.33, 2015.
DOI : 10.1016/S1072-7515(01)00832-8

C. Carter, C. Allen, and D. Henson, Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases, Cancer, vol.45, issue.1, pp.181-187, 1989.
DOI : 10.1038/bjc.1979.139

S. Pinder, I. Ellis, M. Galea, S. O-'rouke, R. Blamey et al., Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up, Histopathology, vol.56, issue.1, pp.41-47, 1994.
DOI : 10.1038/bjc.1987.230

E. De-azambuja, F. Cardoso, G. De-castro, M. Colozza, M. Mano et al., Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12???155 patients, British Journal of Cancer, vol.27, issue.10, pp.1504-1517, 2007.
DOI : 10.1002/1097-0142(19910115)67:2<421::AID-CNCR2820670217>3.0.CO;2-Q

M. Hammond, D. Hayes, M. Dowsett, D. Allred, K. Hagerty et al., College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer, Erratum Appear Arch Pathol Lab Med, vol.134, p.1101, 2010.

D. Slamon, G. Clark, S. Wong, W. Levin, A. Ullrich et al., Human breast cancer: correlation of relapse and, Science, vol.3798106, issue.177, p.235, 1987.

E. Group, Effect of radiotherapy after breast-conserving surgery on 10- year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. The Lancet, pp.1707-1716, 2011.

H. Bartelink, J. Horiot, P. Poortmans, H. Struikmans, W. Van-den-bogaert et al., Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial, Journal of Clinical Oncology, vol.25, issue.22, pp.3259-65, 2007.
DOI : 10.1200/JCO.2007.11.4991

Y. Kirova, C. Pena, P. Hijal, T. Fournier-bidoz, N. Laki et al., Improving the Definition of Tumor Bed Boost With the Use of Surgical Clips and Image Registration in Breast Cancer Patients, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.5, pp.1352-1357, 2010.
DOI : 10.1016/j.ijrobp.2009.10.049

S. Besnard, B. Cutuli, A. Fourquet, S. Giard, C. Hennequin et al., Radioth??rapie du cancer du sein infiltrant??: recommandations nationales fran??aises, Cancer/Radioth??rapie, vol.16, issue.5-6, pp.503-516, 2012.
DOI : 10.1016/j.canrad.2012.07.181

J. Lacour, M. Le, and E. Caceres, Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer, Cancer, vol.35, issue.10, pp.1941-1943, 1983.
DOI : 10.1038/bjc.1977.1

URL : http://onlinelibrary.wiley.com/doi/10.1002/1097-0142(197601)37:1<206::AID-CNCR2820370130>3.0.CO;2-M/pdf

E. Group, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. The Lancet, pp.2087-2106, 2006.

T. Whelan, I. Olivotto, W. Parulekar, I. Ackerman, B. Chua et al., Regional Nodal Irradiation in Early-Stage Breast Cancer, New England Journal of Medicine, vol.373, issue.4, pp.307-323, 2015.
DOI : 10.1056/NEJMoa1415340

P. Poortmans, S. Collette, C. Kirkove, E. Van-limbergen, V. Budach et al., Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer, New England Journal of Medicine, vol.373, issue.4, pp.317-344, 2015.
DOI : 10.1056/NEJMoa1415369

URL : https://hal.archives-ouvertes.fr/hal-00486378

M. Donker, G. Van-tienhoven, M. Straver, P. Meijnen, C. Van-de-velde et al., Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial, The Lancet Oncology, vol.15, issue.12, pp.1303-1313, 2014.
DOI : 10.1016/S1470-2045(14)70460-7

V. Galimberti, B. Cole, S. Zurrida, G. Viale, A. Luini et al., Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23???01): a phase 3 randomised controlled trial, The Lancet Oncology, vol.14, issue.4, pp.297-305, 2013.
DOI : 10.1016/S1470-2045(13)70035-4

A. Giuliano, K. Ballman, L. Mccall, P. Beitsch, P. Whitworth et al., Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases, Annals of Surgery, vol.264, issue.3, pp.413-433, 2016.
DOI : 10.1097/SLA.0000000000001863

. Sávolt-Á, G. Péley, C. Polgár, N. Udvarhelyi, G. Rubovszky et al., Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla ??? Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer, European Journal of Surgical Oncology (EJSO), vol.43, issue.4, pp.672-681, 2017.
DOI : 10.1016/j.ejso.2016.12.011

L. Thorsen, B. Offersen, H. Danø, M. Berg, I. Jensen et al., DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer, Journal of Clinical Oncology, vol.34, issue.4, pp.314-334, 2016.
DOI : 10.1200/JCO.2015.63.6456

R. Tanz, N. Magne, P. Annede, B. Mery, J. Jacob et al., Vers une approche intégrée des toxicités cardiovasculaires liées aux traitements du cancer du sein, Bull Cancer (Paris), vol.101, issue.7, pp.730-740, 2014.

E. De-azambuja, M. Procter, D. Van-veldhuisen, D. Agbor-tarh, O. Metzger-filho et al., Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01), Journal of Clinical Oncology, vol.32, issue.20, pp.2159-65, 2014.
DOI : 10.1200/JCO.2013.53.9288

C. Pinnix, G. Perkins, E. Strom, W. Tereffe, W. Woodward et al., Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase III Clinical Trial, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.4, pp.1089-94, 2012.
DOI : 10.1016/j.ijrobp.2011.09.021

L. Bazire, I. Fromantin, A. Diallo, . Lande-b-de-la, V. Pernin et al., Hydrosorb?? versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial, Radiotherapy and Oncology, vol.117, issue.2, pp.229-262, 2015.
DOI : 10.1016/j.radonc.2015.08.028

T. Buchholz, Radiation Therapy for Early-Stage Breast Cancer after Breast-Conserving Surgery, New England Journal of Medicine, vol.360, issue.1, pp.63-70, 2009.
DOI : 10.1056/NEJMct0803525

C. Vrieling, L. Collette, A. Fourquet, and W. Hoogenraad, The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ???boost vs. no boost??? trial, Radiotherapy and Oncology, vol.55, issue.3, pp.219-232, 2000.
DOI : 10.1016/S0167-8140(00)00210-3

G. Barnett, J. Wilkinson, A. Moody, C. Wilson, N. Twyman et al., The Cambridge Breast Intensity-modulated Radiotherapy Trial: Patient- and Treatment-related Factors that Influence Late Toxicity, Clinical Oncology, vol.23, issue.10, pp.662-73, 2011.
DOI : 10.1016/j.clon.2011.04.011

S. Darby, M. Ewertz, P. Mcgale, A. Bennet, U. Blom-goldman et al., Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer, New England Journal of Medicine, vol.368, issue.11, pp.987-98, 2013.
DOI : 10.1056/NEJMoa1209825

S. Darby, P. Mcgale, C. Taylor, and R. Peto, Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300???000 women in US SEER cancer registries, The Lancet Oncology, vol.6, issue.8, pp.557-565, 2005.
DOI : 10.1016/S1470-2045(05)70251-5

M. Ryberg, D. Nielsen, C. G. Nielsen, G. Skovsgaard, T. Andersen et al., New Insight Into Epirubicin Cardiac Toxicity: Competing Risks Analysis of 1097 Breast Cancer Patients, JNCI: Journal of the National Cancer Institute, vol.33, issue.1, pp.1058-67, 2008.
DOI : 10.1053/j.seminoncol.2006.04.022

J. Jacob, L. Belin, A. Gobillion, C. Daveau-bergerault, R. Dendale et al., ??tude prospective monocentrique de la toxicit?? et de l???efficacit?? du trastuzumab concomitant ?? la radioth??rapie, Cancer/Radioth??rapie, vol.17, issue.3, pp.183-90, 2013.
DOI : 10.1016/j.canrad.2012.12.006

Z. Kahán, M. Csenki, Z. Varga, E. Szil, A. Cserháti et al., The Risk of Early and Late Lung Sequelae After Conformal Radiotherapy in Breast Cancer Patients, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.3, pp.673-81, 2007.
DOI : 10.1016/j.ijrobp.2006.12.016

T. Lingos, A. Recht, F. Vicini, A. Abner, B. Silver et al., Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.2, pp.355-360, 1991.
DOI : 10.1016/0360-3016(91)90782-Y

C. Ortholan and F. Mornex, Dose de tol??rance ?? l???irradiation des tissus sains??: le poumon, Cancer/Radioth??rapie, vol.14, issue.4-5, pp.312-320, 2010.
DOI : 10.1016/j.canrad.2010.02.009

Y. Kirova, L. Gambotti, Y. De-rycke, J. Vilcoq, B. Asselain et al., Risk of Second Malignancies After Adjuvant Radiotherapy for Breast Cancer: A Large-Scale, Single-Institution Review, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.2, pp.359-63, 2007.
DOI : 10.1016/j.ijrobp.2006.12.011

L. Bazire, Y. De-rycke, B. Asselain, A. Fourquet, and Y. Kirova, Risks of second malignancies after breast cancer treatment: Long-term results. Cancer/Radioth?rapie, févr, vol.21, issue.1, pp.10-15, 2017.

C. Nutting, J. Morden, K. Harrington, T. Urbano, S. Bhide et al., Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial, The Lancet Oncology, vol.12, issue.2, pp.127-136, 2011.
DOI : 10.1016/S1470-2045(10)70290-4

E. Butler, B. Teh, W. Grant, B. Uhl, R. Kuppersmith et al., Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.1, pp.21-32, 1999.
DOI : 10.1016/S0360-3016(99)00101-7

D. Azria, N. Aillères, L. Moscardo, C. Hay, M. Dubois et al., Radioth??rapie de conformation avec modulation d???intensit?? dans le cancer de prostate??: vers un nouveau standard, Cancer/Radioth??rapie, vol.13, issue.5, pp.409-424, 2009.
DOI : 10.1016/j.canrad.2008.12.004

P. Fenoglietto, B. Laliberte, A. Allaw, N. Ailleres, K. Idri et al., Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk, Radiotherapy and Oncology, vol.88, issue.1, pp.77-87, 2008.
DOI : 10.1016/j.radonc.2007.12.011

S. Peeters, W. Heemsbergen, P. Koper, W. Van-putten, A. Slot et al., Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy, Journal of Clinical Oncology, vol.24, issue.13, 2006.
DOI : 10.1200/JCO.2005.05.2530

A. Zietman, M. Desilvio, J. Slater, and C. Rossi, Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate, JAMA, vol.294, issue.10, pp.1233-1239, 2005.
DOI : 10.1001/jama.294.10.1233

P. Kupelian, V. Thakkar, D. Khuntia, C. Reddy, E. Klein et al., Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.5, pp.1463-1471, 2005.
DOI : 10.1016/j.ijrobp.2005.05.054

V. Rudat, A. Alaradi, A. Mohamed, A. Khaled, and S. Altuwaijri, Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: A dosimetric comparison, Radiation Oncology, vol.6, issue.1, p.26, 2011.
DOI : 10.1016/S0360-3016(03)00073-7

B. Teh, H. Lu, S. Sobremonte, D. Bellezza, J. Chiu et al., The Potential Use of Intensity Modulated Radiotherapy (IMRT) in Women with Pectus Excavatum Desiring Breast-Conserving Therapy, The Breast Journal, vol.26, issue.4, pp.233-239, 2001.
DOI : 10.1016/0360-3016(93)90287-6

A. Teh, L. Walsh, T. Purdie, A. Mosseri, W. Xu et al., Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy ??? A feasibility and toxicity study, Radiotherapy and Oncology, vol.102, issue.1, pp.89-95, 2012.
DOI : 10.1016/j.radonc.2011.10.015

R. Singla, S. King, K. Albuquerque, S. Creech, and N. Dogan, Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma, Medical Dosimetry, vol.31, issue.3, pp.190-196, 2006.
DOI : 10.1016/j.meddos.2005.11.001

L. Kestin, M. Sharpe, R. Frazier, F. Vicini, D. Yan et al., Intensity modulation to improve dose uniformity with tangential breast radiotherapy: Initial clinical experience, International Journal of Radiation Oncology*Biology*Physics, vol.48, issue.5, pp.1559-1568, 2000.
DOI : 10.1016/S0360-3016(00)01396-1

G. Barnett, J. Wilkinson, A. Moody, C. Wilson, R. Sharma et al., A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: Baseline characteristics and dosimetry results, Radiotherapy and Oncology, vol.92, issue.1, pp.34-41, 2009.
DOI : 10.1016/j.radonc.2009.03.003

B. Cho, C. Hurkmans, E. Damen, L. Zijp, and B. Mijnheer, Intensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study, Radiotherapy and Oncology, vol.62, issue.2, pp.127-136, 2002.
DOI : 10.1016/S0167-8140(01)00472-8

O. Riou, P. Fenoglietto, C. Lemanski, and D. Azria, Radioth??rapie conformationnelle avec modulation d???intensit?? dans les cancers du sein??: int??r??t, limitations, modalit??s techniques, Cancer/Radioth??rapie, vol.16, issue.5-6, pp.479-84, 2012.
DOI : 10.1016/j.canrad.2012.05.010

E. Hall and C. Wuu, Radiation-induced second cancers: the impact of 3D-CRT and IMRT, International Journal of Radiation Oncology*Biology*Physics, vol.56, issue.1, pp.83-91, 2003.
DOI : 10.1016/S0360-3016(03)00073-7

T. Mackie, T. Holmes, S. Swerdloff, P. Reckwerdt, J. Deasy et al., Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy, Medical Physics, vol.20, issue.6, pp.1709-1728, 1993.
DOI : 10.1118/1.596958

M. Mukesh, G. Barnett, J. Wilkinson, A. Moody, C. Wilson et al., Randomized Controlled Trial of Intensity-Modulated Radiotherapy for Early Breast Cancer: 5-Year Results Confirm Superior Overall Cosmesis, Journal of Clinical Oncology, vol.31, issue.36, pp.4488-95, 2013.
DOI : 10.1200/JCO.2013.49.7842

V. Gonzalez, D. Buchholz, K. Langen, G. Olivera, B. Chauhan et al., Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.1, pp.284-90, 2006.
DOI : 10.1016/j.ijrobp.2005.12.044

T. Reynders, K. Tournel, D. Coninck, P. Heymann, S. Vinh-hung et al., Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments, Radiotherapy and Oncology, vol.93, issue.1, pp.71-80, 2009.
DOI : 10.1016/j.radonc.2009.07.005

E. Donovan, N. Bleakley, E. Denholm, P. Evans, L. Gothard et al., Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy, Radiotherapy and Oncology, vol.82, issue.3, pp.254-64, 2007.
DOI : 10.1016/j.radonc.2006.12.008

J. Pignol, I. Olivotto, E. Rakovitch, S. Gardner, K. Sixel et al., A Multicenter Randomized Trial of Breast Intensity-Modulated Radiation Therapy to Reduce Acute Radiation Dermatitis, Journal of Clinical Oncology, vol.26, issue.13, pp.2085-92, 2008.
DOI : 10.1200/JCO.2007.15.2488

A. Falk, P. Fenoglietto, D. Azria, and C. Bourgier, Nouvelles techniques de radioth??rapie externe??: exemple de prise en charge dans les cancers du sein, Cancer/Radioth??rapie, vol.18, issue.5-6, pp.480-485, 2014.
DOI : 10.1016/j.canrad.2014.06.018

J. Pignol, P. Truong, E. Rakovitch, M. Sattler, T. Whelan et al., Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial, Radiotherapy and Oncology, vol.121, issue.3, pp.414-423, 2016.
DOI : 10.1016/j.radonc.2016.08.021

C. Popescu, I. Olivotto, W. Beckham, W. Ansbacher, S. Zavgorodni et al., Volumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared to Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary Nodes, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.1, pp.287-95, 2010.
DOI : 10.1016/j.ijrobp.2009.05.038

S. Osman, S. Hol, P. Poortmans, and M. Essers, Volumetric modulated arc therapy and breath-hold in image-guided locoregional left-sided breast irradiation, Radiotherapy and Oncology, vol.112, issue.1, pp.17-22, 2014.
DOI : 10.1016/j.radonc.2014.04.004

G. Nicolini, A. Clivio, A. Fogliata, E. Vanetti, and L. Cozzi, Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy, Radiation Oncology, vol.4, issue.1, p.27, 2009.
DOI : 10.1186/1748-717X-4-27

O. Lauche, Y. Kirova, P. Fenoglietto, E. Costa, C. Lemanski et al., Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy, World Journal of Radiology, vol.8, issue.8, p.735, 2016.
DOI : 10.1120/jacmp.v13i5.3806

Y. Abo-madyan, M. Aziz, M. Aly, F. Schneider, E. Sperk et al., Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer, Radiotherapy and Oncology, vol.110, issue.3, pp.471-477, 2014.
DOI : 10.1016/j.radonc.2013.12.002

B. Lee, S. Lee, J. Sung, and M. Yoon, Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT, Journal of Radiological Protection, vol.34, issue.2, pp.325-356, 2014.
DOI : 10.1088/0952-4746/34/2/325

T. Reynders, K. Tournel, D. Coninck, P. Heymann, S. Vinh-hung et al., Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments, Radiotherapy and Oncology, vol.93, issue.1, pp.71-80, 2009.
DOI : 10.1016/j.radonc.2009.07.005

G. Zhou, S. Xu, X. Dai, Z. Ju, H. Gong et al., Clinical Dosimetric Study of Three Radiotherapy Techniques for Postoperative Breast Cancer: Helical Tomotherapy, IMRT, and 3D-CRT, Technology in Cancer Research & Treatment, vol.10, issue.1, pp.15-23, 2011.
DOI : 10.1016/j.radonc.2008.09.027

T. Hijal, N. Fournier-bidoz, P. Castro-pena, Y. Kirova, S. Zefkili et al., Simultaneous integrated boost in breast conserving treatment of breast cancer: A dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapy, Radiotherapy and Oncology, vol.94, issue.3, pp.300-306, 2010.
DOI : 10.1016/j.radonc.2009.12.043

G. Nilsson, L. Holmberg, H. Garmo, O. Duvernoy, I. Sjögren et al., Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer, Journal of Clinical Oncology, vol.30, issue.4, pp.380-386, 2012.
DOI : 10.1200/JCO.2011.34.5900

J. Caudell, D. Santos, J. Keene, K. Fiveash, J. Wang et al., A Dosimetric Comparison of Electronic Compensation, Conventional Intensity Modulated Radiotherapy, and Tomotherapy in Patients With Early-Stage Carcinoma of the Left Breast, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.5, pp.1505-1516, 2007.
DOI : 10.1016/j.ijrobp.2007.04.026

L. Schubert, V. Gondi, E. Sengbusch, D. Westerly, E. Soisson et al., Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy, Radiotherapy and Oncology, vol.100, issue.2, pp.241-247, 2011.
DOI : 10.1016/j.radonc.2011.01.004

J. Qiu, Z. Liu, Y. B. Hou, X. Zhang, and F. , Low-Dose-Area-Constrained Helical TomoTherapy-Based Whole Breast Radiotherapy and Dosimetric Comparison with Tangential Field-in-Field IMRT, BioMed Research International, vol.93, issue.13, pp.1-6, 2013.
DOI : 10.1186/1748-717X-7-191

J. Caudrelier, S. Morgan, L. Montgomery, M. Lacelle, B. Nyiri et al., Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: Dosimetric evaluation, Radiotherapy and Oncology, vol.90, issue.1, pp.99-105, 2009.
DOI : 10.1016/j.radonc.2008.09.028

S. Goddu, S. Chaudhari, M. Mamalui-hunter, O. Pechenaya, D. Pratt et al., Helical Tomotherapy Planning for Left-Sided Breast Cancer Patients With Positive Lymph Nodes: Comparison to Conventional Multiport Breast Technique, International Journal of Radiation Oncology*Biology*Physics, vol.73, issue.4, pp.1243-51, 2009.
DOI : 10.1016/j.ijrobp.2008.11.004

M. Ashenafi, R. Boyd, T. Lee, K. Lo, J. Gibbons et al., Feasibility of Postmastectomy Treatment With Helical TomoTherapy, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.3, pp.836-878, 2010.
DOI : 10.1016/j.ijrobp.2009.06.027

C. Massabeau, N. Fournier-bidoz, G. Wakil, C. Pena, P. Viard et al., Implant breast reconstruction followed by radiotherapy: Can helical tomotherapy become a standard irradiation treatment?, Medical Dosimetry, vol.37, issue.4, pp.425-456, 2012.
DOI : 10.1016/j.meddos.2012.03.006

F. Lamberth, P. Guilbert, N. Gaillot-petit, C. Champagne, L. Looten-vieren et al., Indications potentielles de la tomoth??rapie h??lico??dale dans les cancers du sein, Cancer/Radioth??rapie, vol.18, issue.1, pp.7-14, 2014.
DOI : 10.1016/j.canrad.2013.07.148

A. Coon, A. Dickler, M. Kirk, Y. Liao, A. Shah et al., Tomotherapy and Multifield Intensity-Modulated Radiotherapy Planning Reduce Cardiac Doses in Left-Sided Breast Cancer Patients With Unfavorable Cardiac Anatomy, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.1, pp.104-114, 2010.
DOI : 10.1016/j.ijrobp.2009.07.1705

X. Liem, C. Chira, A. Fourquet, F. Campana, D. Peurien et al., R??sultats pr??liminaires d???une tomoth??rapie h??lico??dale adjuvante avec boost int??gr?? dans le cadre d???un traitement conservateur d???un cancer du sein, Cancer/Radioth??rapie, vol.18, issue.1, pp.15-22, 2014.
DOI : 10.1016/j.canrad.2013.07.149

A. Arsene-henry, A. Fourquet, and Y. Kirova, Evolution of radiation techniques in the treatment of breast cancer (BC) patients: From 3D conformal radiotherapy (3D CRT) to intensity-modulated RT (IMRT) using Helical Tomotherapy (HT), Radiotherapy and Oncology, vol.124, issue.2
DOI : 10.1016/j.radonc.2017.07.002

C. Chira, Y. Kirova, X. Liem, F. Campana, D. Peurien et al., Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool, BioMed Research International, vol.16, issue.5-6, pp.1-8, 2013.
DOI : 10.1016/j.ijrobp.2005.12.044

M. Duma, C. Heinrich, C. Schönknecht, B. Chizzali, M. Mayinger et al., Helical TomoTherapy for locally advanced or recurrent breast cancer, Radiation Oncology, vol.28, issue.3 Suppl, 2017.
DOI : 10.1016/j.breast.2016.05.004

A. Wojcieszynski, A. Olson, Y. Rong, R. Kimple, and P. Yadav, Acute Toxicity From Breast Cancer Radiation Using Helical Tomotherapy With a Simultaneous Integrated Boost, Technology in Cancer Research & Treatment, vol.15, issue.2, pp.257-65, 2016.
DOI : 10.1056/NEJMoa1209825

N. Aoulad, C. Massabeau, B. De-lafontan, L. Vieillevigne, G. Hangard et al., Toxicit?? aigu?? de la tomoth??rapie des cancers mammaires, Cancer/Radioth??rapie, vol.21, issue.3, 2017.
DOI : 10.1016/j.canrad.2016.11.008

H. Van-parijs, G. Miedema, V. Vinh-hung, S. Verbanck, N. Adriaenssens et al., Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial, Radiation Oncology, vol.7, issue.1, p.80, 2012.
DOI : 10.1016/j.breast.2010.03.003

B. Offersen, L. Boersma, C. Kirkove, S. Hol, M. Aznar et al., ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, Radiotherapy and Oncology, vol.114, issue.1, pp.3-10, 2015.
DOI : 10.1016/j.radonc.2014.11.030

Y. Kirova, C. Pena, P. Hijal, T. Fournier-bidoz, N. Laki et al., Improving the Definition of Tumor Bed Boost With the Use of Surgical Clips and Image Registration in Breast Cancer Patients, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.5, pp.1352-1357, 2010.
DOI : 10.1016/j.ijrobp.2009.10.049

X. Qi, J. White, and X. Li, Is ??/?? for breast cancer really low?, Radiotherapy and Oncology, vol.100, issue.2, pp.282-290, 2011.
DOI : 10.1016/j.radonc.2011.01.010

C. Hurkmans, G. Meijer, C. Van-vliet-vroegindeweij, M. Van-der-sangen, and J. Cassee, High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization, International Journal of Radiation Oncology*Biology*Physics, vol.66, issue.3, pp.923-953, 2006.
DOI : 10.1016/j.ijrobp.2006.05.041

H. Van-der-laan, W. Dolsma, J. Maduro, E. Korevaar, M. Hollander et al., Three-Dimensional Conformal Simultaneously Integrated Boost Technique for Breast-Conserving Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.4, pp.1018-1041, 2007.
DOI : 10.1016/j.ijrobp.2007.01.037

S. Goddu, S. Chaudhari, M. Mamalui-hunter, O. Pechenaya, D. Pratt et al., Helical Tomotherapy Planning for Left-Sided Breast Cancer Patients With Positive Lymph Nodes: Comparison to Conventional Multiport Breast Technique, International Journal of Radiation Oncology*Biology*Physics, vol.73, issue.4, pp.1243-51, 2009.
DOI : 10.1016/j.ijrobp.2008.11.004

G. Barnett, J. Wilkinson, A. Moody, C. Wilson, R. Sharma et al., A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: Baseline characteristics and dosimetry results, Radiotherapy and Oncology, vol.92, issue.1, pp.34-41, 2009.
DOI : 10.1016/j.radonc.2009.03.003

J. Pignol, I. Olivotto, E. Rakovitch, S. Gardner, K. Sixel et al., A Multicenter Randomized Trial of Breast Intensity-Modulated Radiation Therapy to Reduce Acute Radiation Dermatitis, Journal of Clinical Oncology, vol.26, issue.13, pp.2085-92, 2008.
DOI : 10.1200/JCO.2007.15.2488

J. Yang, M. Lee, C. Lin, H. Chao, C. Chen et al., Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy, Medicine, vol.95, issue.11, p.3113, 2016.
DOI : 10.1097/MD.0000000000003113

URL : http://pdfs.journals.lww.com/md-journal/2016/03150/Long_Term_Breast_Cancer_Patient_Outcomes_After.65.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1508398883196;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzddFRrD2hcIwdDP9eSnSkfs2O82KpwxLBPjUIxQwCrF4c=;hash|sBqnoY9pnbp18F9xHfXHvw==

S. Darby, M. Ewertz, P. Mcgale, A. Bennet, U. Blom-goldman et al., Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer, New England Journal of Medicine, vol.368, issue.11, pp.987-98, 2013.
DOI : 10.1056/NEJMoa1209825

J. Caudrelier, S. Morgan, L. Montgomery, M. Lacelle, B. Nyiri et al., Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: Dosimetric evaluation, Radiotherapy and Oncology, vol.90, issue.1, pp.99-105, 2009.
DOI : 10.1016/j.radonc.2008.09.028

V. Remouchamps, F. Vicini, M. Sharpe, L. Kestin, A. Martinez et al., Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation, International Journal of Radiation Oncology*Biology*Physics, vol.55, issue.2, pp.392-406, 2003.
DOI : 10.1016/S0360-3016(02)04143-3

M. Hjelstuen, I. Mjaaland, J. Vikström, and K. Dybvik, Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk, Acta Oncologica, vol.74, issue.3, pp.333-377, 2012.
DOI : 10.1016/j.ijrobp.2008.07.018

G. Borst, J. Sonke, S. Hollander, A. Betgen, P. Remeijer et al., Clinical Results of Image-Guided Deep Inspiration Breath Hold Breast Irradiation, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.5, pp.1345-51, 2010.
DOI : 10.1016/j.ijrobp.2009.10.006

S. Korreman, A. Pedersen, T. Nøttrup, L. Specht, and H. Nyström, Breathing adapted radiotherapy for breast cancer: Comparison of free breathing gating with the breath-hold technique, Radiotherapy and Oncology, vol.76, issue.3, pp.311-319, 2005.
DOI : 10.1016/j.radonc.2005.07.009

H. Nissen and A. Appelt, Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients, Radiotherapy and Oncology, vol.106, issue.1, pp.28-32, 2013.
DOI : 10.1016/j.radonc.2012.10.016

L. Marks, S. Bentzen, J. Deasy, F. Kong, . Spring et al., Radiation Dose???Volume Effects in the Lung, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.3, pp.70-76, 2010.
DOI : 10.1016/j.ijrobp.2009.06.091

J. Boice, E. Harvey, M. Blettner, M. Stovall, and J. Flannery, Cancer in the controlatéral breast after radiotherpy for breast cancer, N Engl J Med, 1992.

M. Stovall, S. Smith, B. Langholz, J. Boice, R. Shore et al., Dose to the Contralateral Breast From Radiotherapy and Risk of Second Primary Breast Cancer in the WECARE Study, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.4, pp.1021-1051, 2008.
DOI : 10.1016/j.ijrobp.2008.02.040